Volume 71, Issue 1, Pages (January 2007)

Slides:



Advertisements
Similar presentations
Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay A. Keppler,
Advertisements

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Bias in clinical research
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Beta blockers in the management of chronic kidney disease
Volume 69, Issue 5, Pages (March 2006)
Linear and logistic regression analysis
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
Volume 67, Issue 5, Pages (May 2005)
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Volume 79, Issue 11, Pages (June 2011)
Volume 65, Issue 5, Pages (May 2004)
Volume 64, Issue 2, Pages (August 2003)
Volume 71, Issue 8, Pages (April 2007)
Volume 78, Issue 12, Pages (December 2010)
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
Volume 71, Issue 1, Pages (January 2007)
How to interpret the eGFR in patients with small body surface area
Comorbidity and confounding in end-stage renal disease
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Enlightenment on liver lanthanum exposure
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Volume 59, Issue 5, Pages (May 2001)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
James D. House, Margaret E. Brosnan, John T. Brosnan 
Blood pressure targets in hemodialysis patients
Fructose intake as a risk factor for kidney stone disease
Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler 
Volume 72, Issue 12, Pages (December 2007)
The third World Kidney Day: Looking back and thinking forward
20-HETE in acute kidney injury
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Crossed fused ectopia of the kidneys
Volume 71, Issue 4, Pages (February 2007)
Volume 71, Issue 4, Pages (February 2007)
Volume 81, Issue 4, Pages (February 2012)
Fibroblast growth factor 23: the making of a hormone
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Organ transplantation goes to the movies
Volume 69, Issue 1, Pages (January 2006)
Volume 72, Issue 3, Pages (August 2007)
Volume 71, Issue 2, Pages (January 2007)
Cellular contributions to glomerular size-selectivity
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Urinalysis in Western culture: A brief history
Volume 70, Issue 3, Pages (August 2006)
Assessing the impact of different imputation methods on serial measures of renal function: The Strong Heart Study  N.-M. Shara, J.-G. Umans, W. Wang,
Volume 71, Issue 9, Pages (May 2007)
Volume 70, Issue 5, Pages (September 2006)
Volume 72, Issue 11, Pages (December 2007)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Volume 61, Issue 1, Pages (January 2002)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 69, Issue 3, Pages (February 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
A. Lauschke, U.K.M. Teichgräber, U. Frei, K.-U. Eckardt 
The Ebf1 knockout mouse and glomerular maturation
P.A. McFarlane, A.M. Bayoumi, A. Pierratos, D.A. Redelmeier 
Presentation transcript:

Volume 71, Issue 1, Pages 74-78 (January 2007) Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay  A. Keppler, N. Gretz, R. Schmidt, H-M. Kloetzer, H-J. Groene, B. Lelongt, M. Meyer, M. Sadick, J. Pill  Kidney International  Volume 71, Issue 1, Pages 74-78 (January 2007) DOI: 10.1038/sj.ki.5001988 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Method comparison of creatinine measurement in mouse and rat plasma. Comparison of HPLC, enzymatic, and colorimetric method in (a–d) mice and (e–h) rats. (a, c, e, and g) scatter plots with regression line (solid), line of identity (broken), regression equation, and coefficient of determination (r2) as well as (b, d, f, h) Bland–Altman plots for the comparison of creatinine concentrations in spiked (0.4mg/dl creatinine added) and unspiked plasma of healthy as well as diseased mice (n=61, plus 61 spiked samples) and rats (n=56, plus 56 spiked samples) are depicted. Comparisons between the enzymatic method and HPLC (a and b) mice, (e and f) rats and the colorimetric method and HPLC (c and d) mice, (g and h) rats are shown in this figure, whereas the comparison between the enzymatic and colorimetric method is added as Supplementary Material. In the Bland–Altman plots the middle line indicates the mean difference; the outer lines indicate the limits of agreement (mean±2s.d.). Calibration curves for HPLC were for mice: y=0.0654x+0.0187, r2=0.9981, and rats: y=0.0654x–0.0335, r2=0.994. Figure 1 continued on the following page. Kidney International 2007 71, 74-78DOI: (10.1038/sj.ki.5001988) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Method comparison of creatinine measurement in mouse and rat plasma. Comparison of HPLC, enzymatic, and colorimetric method in (a–d) mice and (e–h) rats. (a, c, e, and g) scatter plots with regression line (solid), line of identity (broken), regression equation, and coefficient of determination (r2) as well as (b, d, f, h) Bland–Altman plots for the comparison of creatinine concentrations in spiked (0.4mg/dl creatinine added) and unspiked plasma of healthy as well as diseased mice (n=61, plus 61 spiked samples) and rats (n=56, plus 56 spiked samples) are depicted. Comparisons between the enzymatic method and HPLC (a and b) mice, (e and f) rats and the colorimetric method and HPLC (c and d) mice, (g and h) rats are shown in this figure, whereas the comparison between the enzymatic and colorimetric method is added as Supplementary Material. In the Bland–Altman plots the middle line indicates the mean difference; the outer lines indicate the limits of agreement (mean±2s.d.). Calibration curves for HPLC were for mice: y=0.0654x+0.0187, r2=0.9981, and rats: y=0.0654x–0.0335, r2=0.994. Figure 1 continued on the following page. Kidney International 2007 71, 74-78DOI: (10.1038/sj.ki.5001988) Copyright © 2007 International Society of Nephrology Terms and Conditions